Aytu Biopharma (AYTU) Other financing activities (2013 - 2022)

Aytu Biopharma (AYTU) has reported Other financing activities for 8 consecutive years, with -$51000.0 the latest figure, recorded in Q4 2022.

• On a quarterly basis, Other financing activities changed N/A year-over-year to -$51000.0 in Q4 2022; TTM through Dec 2022 was -$65000.0, a 100.5% decrease from a year earlier, with the FY2022 full-year figure at -$7000.0, down 40.0% from the prior year.
• Other financing activities was -$51000.0 for Q4 2022 at Aytu Biopharma, down from -$13000.0 in the prior quarter.
• Over five years, Other financing activities peaked at $9.0 million in Q1 2020 and troughed at -$51000.0 in Q4 2022.
• A 5-year average of $1.6 million and a median of $17860.0 in 2018 frame the typical range for Other financing activities.
• Across the five-year window, Other financing activities soared 3335.07% in 2020 and sank 116.67% in 2022, its largest moves.
• Over 5 years, Other financing activities stood at $36720.0 in 2018, then surged by 217.3% to $116514.0 in 2019, then soared by 3335.07% to $4.0 million in 2020, then slumped by 100.15% to -$6000.0 in 2021, then sank by 750.0% to -$51000.0 in 2022.
• The last three Other financing activities figures came in at -$51000.0 (Q4 2022), -$13000.0 (Q3 2022), and -$1000.0 (Q1 2022), per Business Quant data.